Ivermectin Headlines Resurface as CDC Faces Credibility Questions
In 2025, ivermectin headlines have resurfaced amid growing scrutiny of the CDC’s credibility. Debates over transparency, trust, and drug safety have intensified as the public questions the agency’s messaging on COVID-19 and alternative treatments. Once primarily recognized for its antiparasitic properties, ivermectin has become emblematic of broader discussions about public health...
0 Comentários 0 Compartilhamentos 83 Visualizações